Neurocrine Biosciences (NBIX) Tax Rate Growth (1y) (2020 - 2026)
Neurocrine Biosciences (NBIX) Tax Rate Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.01 Bn | 87.15 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.73 Bn | 16.41 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.56 Bn | 12.14 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.48 Bn | 10.33 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,644.00 |
| Dec 31, 2025 | -80.00 |
| Sep 30, 2025 | -359.00 |
| Jun 30, 2025 | -148.00 |
| Mar 31, 2025 | 7,206.00 |
| Dec 31, 2024 | 1,111.00 |
| Sep 30, 2024 | 368.00 |
| Jun 30, 2024 | 1,261.00 |
| Mar 31, 2024 | -5,164.00 |
| Dec 31, 2023 | 97.00 |
| Sep 30, 2023 | -192.00 |
| Jun 30, 2023 | -600.00 |
| Mar 31, 2023 | -920.00 |
| Dec 31, 2022 | -2,259.00 |
| Sep 30, 2022 | 380.00 |
| Jun 30, 2022 | 103.00 |
| Mar 31, 2022 | 5,306.00 |
| Dec 31, 2021 | 78,139.00 |
| Sep 30, 2021 | 2,711.00 |
| Jun 30, 2021 | 2,211.00 |